Citation Impact
Citing Papers
Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey
2008 Standout
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
2014
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Drug assay using antibody mimics made by molecular imprinting
1993 StandoutNature
Immunoassay of Theophylline by Latex Particle Counting
1990
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Calcium‐sodium antagonism on the frog's heart: a voltage‐clamp study.
1976
The evolutionary biology of child health
2011
The generation of electric currents in cardiac fibers by Na/Ca exchange
1979 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
2015
Works of Beate Walter being referenced
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
2013
Intrauterine Growth Retardation Associated with Precocious Puberty and Sertoli Cell Hyperplasia
2010
Dry-reagent strips used for determination of theophylline in serum.
1985
Correlation of Na-withdrawal effects on Ca-mediated action potentials and contractile activity in cat ventricular myocardium
1974